Back to all studies
CompletedNCT01104779

Safety study of cariprazine in schizophrenia

This study is completed in the United States, in Colombia, in India, .... It is testing cariprazine for schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether the Safety and Efficacy of Cariprazine may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive the Safety and Efficacy of Cariprazine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Colombia, in India, and in South Africa.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: April 27, 2010
Recruitment status
Completed
Enrollment listed in the registry
446
Sponsor
Forest Laboratories
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Colombia, India, ...
Age range
From 18 Years to 60 Years
Official registry ID
NCT01104779
Official title
A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01104779. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Colombia · 4 sites
  • Forest Investigative Site 601
    Bello, Antioquia
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 604
    Pereira, Risaralda Department
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 602
    Bogotá
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 605
    Bogotá
    Site status: Not listed — confirm with the team
India · 19 sites
  • Forest Investigative Site 505
    Vijayawada, Andhra Pradesh
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 514
    Visakhapatnam, Andhra Pradesh
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 503
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 519
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 501
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 508
    Ahmedabad, Gujarat
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 504
    Bangalore, Karna
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 517
    Mangalore, Karna
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 515
    Mangalore, Karna
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 516
    Mysore, Karna
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 500
    Aurangabad, Mahara
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 510
    Mumbai, Mahara
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 513
    Nashik, Mahara
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 511
    Pune, Mahara
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 502
    Pune, Mahara
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 509
    Rajkot, Rajasthan
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 507
    Kanpur, Uttar Pradesh
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 518
    Lucknow, Uttar Pradesh
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 506
    Varanasi, Uttar Pradesh
    Site status: Not listed — confirm with the team
South Africa · 3 sites
  • Forest Investigative Site 704
    Johannesburg, Gauteng
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 703
    Cape Town, W Cape
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 706
    Cape Town, W Cape
    Site status: Not listed — confirm with the team
United States · 15 sites
  • Forest Investigative Site 48
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 50
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 42
    Paramount, California
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 054
    San Diego, California
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 41
    Kissimmee, Florida
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 055
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 44
    Rockville, Maryland
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 45
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 52
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 40
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 46
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 47
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Forest Investigative 49
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 51
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Forest Investigative Site 43
    Irving, Texas
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Cariprazine, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 60 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Forest Laboratories, which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me